Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy.
Nat Med. 2019 Apr;25(4):656-666. doi: 10.1038/s41591-019-0374-x. Epub 2019 Mar 4.
Nat Med. 2019.
PMID: 30833750
Free PMC article.